Medicare Rx Price Negotiation Gets Finance Cmte. Ally With Sen. Stabenow
Supporters of government price negotiations for Medicare Part D prescription drugs will have another Senate Finance Committee ally in the next Congress, with the appointment of Sen. Debbie Stabenow (D-Mich.)
You may also be interested in...
Questionable citizen petitions will be referred to the Federal Trade Commission, FDA says in a report made to House and Senate appropriations committees
Emerging discussions on the creation of a user fee program for generic drug review place FDA in the awkward position of potentially being seen as an arbiter of drug prices - at least indirectly
Senate reimportation advocates want answers from FDA Commissioner McClellan on drug pricing issues before they will consider his nomination to head CMS